Page last updated: 2024-10-28

hexahydrosiladifenidol and Brain Neoplasms

hexahydrosiladifenidol has been researched along with Brain Neoplasms in 1 studies

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reeve, HL1
Vaughan, PF1
Peers, C1

Other Studies

1 other study available for hexahydrosiladifenidol and Brain Neoplasms

ArticleYear
Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors.
    Neuropharmacology, 1995, Volume: 34, Issue:3

    Topics: Brain Neoplasms; Calcium Channel Blockers; GTP-Binding Proteins; Humans; Muscarine; Muscarinic Agoni

1995